Profile data is unavailable for this security.
About the company
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle brand. The Company sells products designed to serve the particular needs of healthcare professionals primarily through its direct-to-consumer (DTC) digital platform, consisting of its Website, mobile app and B2B business (TEAMS). Its offerings include scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. Its non-scrubwear products are designed as an integrated system that complements its scrubwear and are comprised of base layer and outer layer products. Its underscrubs include sports bras, performance leggings, performance tops and super-soft pima cotton tops. Its under underscrubs include several styles of underwear. Its outer layer products include footwear, lab coats, and a variety of vests, jackets, and fleeces. It also offers necessities, such as scrub caps, lanyards, badge reels, tote bags, baseball caps and beanies.
- Revenue in USD (TTM)548.65m
- Net income in USD10.84m
- Incorporated2013
- Employees354.00
- LocationFigs Inc2834 Colorado Avenue, Suite 100SANTA MONICA 90404United StatesUSA
- Fax+1 (302) 674-5266
- Websitehttps://www.wearfigs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orthopediatrics Corp | 189.67m | -28.44m | 604.87m | 247.00 | -- | 1.63 | -- | 3.19 | -1.24 | -1.24 | 8.26 | 15.32 | 0.4116 | 0.4509 | 4.71 | 767,906.90 | -6.17 | -5.40 | -6.78 | -5.93 | 73.68 | 75.09 | -15.00 | -15.92 | 3.68 | -29.23 | 0.1638 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| AxoGen Inc | 180.86m | -14.31m | 612.30m | 426.00 | -- | 6.18 | -- | 3.39 | -0.3302 | -0.3302 | 4.16 | 2.26 | 0.9356 | 1.65 | 7.55 | 424,544.60 | -7.40 | -13.92 | -8.49 | -15.84 | 76.13 | 79.74 | -7.91 | -20.28 | 2.47 | -1.50 | 0.3224 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Paragon 28 Inc | 235.44m | -59.07m | 637.14m | 430.00 | -- | 4.34 | -- | 2.71 | -0.7132 | -0.7132 | 2.84 | 1.76 | 0.7703 | 0.6049 | 6.63 | 547,539.60 | -19.33 | -- | -23.48 | -- | 76.67 | -- | -25.09 | -- | 1.70 | -5.30 | 0.4295 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
| Mesa Laboratories Inc | 228.38m | -245.65m | 643.37m | 736.00 | -- | 3.99 | -- | 2.82 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Simulations Plus Inc | 70.01m | 9.95m | 645.16m | 243.00 | 65.69 | 3.53 | 41.31 | 9.21 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| SI-Bone Inc | 150.71m | -40.85m | 663.77m | 344.00 | -- | 4.01 | -- | 4.40 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Pacific Biosciences of California Inc | 188.87m | -400.38m | 670.42m | 796.00 | -- | 1.36 | -- | 3.55 | -1.50 | -1.50 | 0.7099 | 1.81 | 0.1125 | 2.05 | 6.69 | 237,275.10 | -23.85 | -16.19 | -26.63 | -17.81 | 26.01 | 37.35 | -211.99 | -136.21 | 7.14 | -22.46 | 0.6444 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Iradimed Corp | 71.31m | 18.63m | 726.82m | 148.00 | 39.28 | 8.71 | 37.36 | 10.19 | 1.46 | 1.46 | 5.59 | 6.59 | 0.7851 | 1.42 | 6.16 | 481,791.50 | 20.51 | 13.16 | 22.48 | 14.58 | 77.14 | 76.55 | 26.12 | 21.46 | 7.82 | 143.27 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
| Orthofix Medical Inc | 784.25m | -119.03m | 765.05m | 1.63k | -- | 1.45 | -- | 0.9755 | -3.14 | -3.14 | 20.72 | 13.76 | 0.8844 | 1.17 | 6.56 | 479,956.60 | -13.42 | -8.88 | -16.31 | -10.96 | 68.05 | 72.37 | -15.18 | -9.28 | 1.11 | -3.12 | 0.2069 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
| Figs Inc | 548.65m | 10.84m | 811.59m | 354.00 | 80.49 | 2.00 | 49.00 | 1.48 | 0.059 | 0.059 | 3.08 | 2.38 | 1.11 | 1.33 | 65.26 | 1,549,845.00 | 2.20 | -- | 2.64 | -- | 67.67 | -- | 1.97 | -- | 3.28 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Standard Biotools Inc | 155.90m | -170.60m | 830.14m | 534.00 | -- | 1.70 | -- | 5.32 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Embecta Corp | 1.12bn | 69.70m | 909.96m | 2.20k | 13.07 | -- | 8.40 | 0.8133 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Cytek Biosciences Inc | 201.21m | -10.16m | 940.27m | 645.00 | -- | 2.41 | -- | 4.67 | -0.0782 | -0.0782 | 1.52 | 2.97 | 0.3982 | 1.60 | 3.72 | 297,647.90 | -2.01 | -- | -2.29 | -- | 54.92 | -- | -5.05 | -- | 5.47 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Castle Biosciences Inc | 311.88m | 6.08m | 946.09m | 610.00 | 168.97 | 2.14 | 48.45 | 3.03 | 0.1999 | 0.1999 | 11.07 | 15.77 | 0.6562 | 9.15 | 7.15 | 511,275.40 | 1.28 | -9.43 | 1.40 | -10.17 | 81.90 | 80.58 | 1.95 | -28.46 | 7.64 | -- | 0.0228 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
| Avanos Medical Inc | 681.50m | 21.70m | 950.85m | 3.77k | 44.22 | 0.7732 | 14.07 | 1.40 | 0.4679 | 0.3385 | 14.70 | 26.76 | 0.4031 | 1.90 | 5.16 | 180,721.30 | 1.28 | -0.6527 | 1.45 | -0.7338 | 55.51 | 54.45 | 3.18 | -1.60 | 1.46 | 9.84 | 0.1164 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Bioventus Inc | 536.89m | -41.96m | 1.01bn | 1.03k | -- | 6.67 | -- | 1.88 | -0.6595 | -0.6595 | 8.48 | 1.86 | 0.6591 | 1.95 | 4.18 | 553,495.90 | -6.70 | -5.52 | -9.65 | -7.27 | 66.53 | 68.25 | -10.16 | -10.94 | 0.956 | 1.08 | 0.6697 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
Data as of Nov 13 2024. Currency figures normalised to Figs Inc's reporting currency: US Dollar USD
51.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BAMCO, Inc.as of 30 Jun 2024 | 26.69m | 16.42% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 12.26m | 7.54% |
| T. Rowe Price Investment Management, Inc.as of 30 Jun 2024 | 10.22m | 6.29% |
| Threadneedle Asset Management Ltd.as of 30 Jun 2024 | 9.93m | 6.11% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 9.09m | 5.59% |
| Eagle Asset Management, Inc.as of 30 Jun 2024 | 3.57m | 2.20% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 3.17m | 1.95% |
| Geode Capital Management LLCas of 30 Jun 2024 | 2.87m | 1.76% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 2.70m | 1.66% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 2.58m | 1.59% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
